rs138768408
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001256317.3(TMPRSS3):c.616+5G>A variant causes a splice region, intron change. The variant allele was found at a frequency of 0.000164 in 1,614,068 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 2/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_001256317.3 splice_region, intron
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TMPRSS3 | NM_001256317.3 | c.616+5G>A | splice_region_variant, intron_variant | ENST00000644384.2 | NP_001243246.1 | |||
TMPRSS3 | NM_024022.4 | c.616+5G>A | splice_region_variant, intron_variant | NP_076927.1 | ||||
TMPRSS3 | NM_032405.2 | c.616+5G>A | splice_region_variant, intron_variant | NP_115781.1 | ||||
TMPRSS3 | NM_032404.3 | c.235+5G>A | splice_region_variant, intron_variant | NP_115780.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TMPRSS3 | ENST00000644384.2 | c.616+5G>A | splice_region_variant, intron_variant | NM_001256317.3 | ENSP00000494414.1 |
Frequencies
GnomAD3 genomes AF: 0.0000986 AC: 15AN: 152168Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000179 AC: 45AN: 251342Hom.: 0 AF XY: 0.000184 AC XY: 25AN XY: 135862
GnomAD4 exome AF: 0.000170 AC: 249AN: 1461782Hom.: 0 Cov.: 31 AF XY: 0.000176 AC XY: 128AN XY: 727200
GnomAD4 genome AF: 0.0000985 AC: 15AN: 152286Hom.: 0 Cov.: 32 AF XY: 0.0000940 AC XY: 7AN XY: 74470
ClinVar
Submissions by phenotype
not provided Uncertain:2
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Jul 16, 2024 | Identified in a patient with sensorineural hearing loss in published literature (PMID: 34515852); In silico analysis is inconclusive as to whether the variant alters gene splicing. In the absence of RNA/functional studies, the actual effect of this sequence change is unknown.; This variant is associated with the following publications: (PMID: 34515852) - |
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Feb 22, 2022 | This sequence change falls in intron 7 of the TMPRSS3 gene. It does not directly change the encoded amino acid sequence of the TMPRSS3 protein. It affects a nucleotide within the consensus splice site. This variant is present in population databases (rs138768408, gnomAD 0.03%). This variant has not been reported in the literature in individuals affected with TMPRSS3-related conditions. ClinVar contains an entry for this variant (Variation ID: 46124). Variants that disrupt the consensus splice site are a relatively common cause of aberrant splicing (PMID: 17576681, 9536098). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Dec 31, 2015 | Variant classified as Uncertain Significance - Favor Benign. The c.616+5G>A vari ant in TMPRSS3 has been reported by our laboratory in 1 Caucasian individual wit h hearing loss, who was compound heterozygous for 2 pathogenic variants in USH2A , which likely explained this individual's hearing loss. This variant has been identified in 30/65986 European chromosomes by the Exome Aggregation Consortium (ExAC, http://exac.broadinstitute.org; dbSNP rs138768408). Although it has been seen in the general population, its frequency is not high enough to rule out a p athogenic role. This variant is located in the 5' splice region. Computational t ools do not suggest an impact to splicing. However, this information is not pred ictive enough to rule out pathogenicity. In summary, while the clinical signific ance of the c.616+5G>A variant is uncertain, these data suggest that it is more likely to be benign. - |
Autosomal recessive nonsyndromic hearing loss 8 Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jan 13, 2018 | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score, this variant could not be ruled out of causing disease and therefore its association with disease required further investigation. A literature search was performed for the gene, cDNA change, and amino acid change (if applicable). No publications were found based on this search. This variant was therefore classified as a variant of unknown significance for this disease. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at